{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:11:58Z","timestamp":1775470318876,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":549,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1111\/bjd.12669","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T15:06:38Z","timestamp":1381935998000},"page":"565-570","source":"Crossref","is-referenced-by-count":13,"title":["Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K."],"prefix":"10.1093","volume":"170","author":[{"given":"F.","family":"Meredith","sequence":"first","affiliation":[{"name":"Dermatology Department; Aberdeen Royal Infirmary; Aberdeen U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Abbott","sequence":"additional","affiliation":[{"name":"Dermatology Department; University Hospital of Wales; Cardiff U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,12]]},"reference":[{"key":"10.1111\/bjd.12669-BIB0001|bjd12669-cit-0001","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/gm199","article-title":"The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma","volume":"2","author":"Spritz","year":"2010","journal-title":"Genome Med"},{"key":"10.1111\/bjd.12669-BIB0002|bjd12669-cit-0002","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/bjd.12669-BIB0003|bjd12669-cit-0003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"10.1111\/bjd.12669-BIB0004|bjd12669-cit-0004","doi-asserted-by":"crossref","unstructured":"Ta\u00efeb A Picardo M Epidemiology, definitions and classification Vitiligo Berlin, Heidelberg Springer 2010","DOI":"10.1007\/978-3-540-69361-1"},{"key":"10.1111\/bjd.12669-BIB0005|bjd12669-cit-0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the managment of of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Ta\u00efeb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0006|bjd12669-cit-0006","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Clinical practice. Vitiligo","volume":"360","author":"Ta\u00efeb","year":"2009","journal-title":"N Eng J Med"},{"key":"10.1111\/bjd.12669-BIB0007|bjd12669-cit-0007","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2133.2011.10311.x","article-title":"Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients","volume":"165","author":"Ezzedine","year":"2011","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.12669-BIB0008|bjd12669-cit-0008","first-page":"S102","article-title":"Latent class analysis of 997 patients with non-segmental vitiligo identify two clinical subtypes","volume":"133","author":"Ezzedine","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12669-BIB0009|bjd12669-cit-0009","unstructured":"XXII International Pigmentary Cell Conference http:\/\/www.ipcc2014.org"},{"key":"10.1111\/bjd.12669-BIB0010|bjd12669-cit-0010","first-page":"1","article-title":"Interventions for vitiligo","volume":"25","author":"Whitton","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.12669-BIB0011|bjd12669-cit-0011","first-page":"1","article-title":"Interventions for vitiligo","volume":"20","author":"Whitton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bjd.12669-BIB0012|bjd12669-cit-0012","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0013|bjd12669-cit-0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0974-2077.79181","article-title":"A review of non-cultured epidermal cellular grafting in vitiligo","volume":"4","author":"Geel","year":"2011","journal-title":"J Cutan Aesthet Surg"},{"key":"10.1111\/bjd.12669-BIB0014|bjd12669-cit-0014","first-page":"530","article-title":"Future reseach into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership","volume":"164","author":"Eleftheriadou","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0015|bjd12669-cit-0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0781.2012.00648.x","article-title":"Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy","volume":"28","author":"Hallaji","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/bjd.12669-BIB0016|bjd12669-cit-0016","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0781.2010.00530.x","article-title":"Recent onset vitiligo on acral areas treated with phototherapy: need of early treatment","volume":"26","author":"Lee","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/bjd.12669-BIB0017|bjd12669-cit-0017","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1684\/ejd.2009.0779","article-title":"An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo","volume":"19","author":"Stinco","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0018|bjd12669-cit-0018","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2011.04002.x","article-title":"Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right\/left double-blind comparative study","volume":"25","author":"Nordal","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12669-BIB0019|bjd12669-cit-0019","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12669-BIB0020|bjd12669-cit-0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","article-title":"The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo","volume":"149","author":"Grimes","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.12669-BIB0021|bjd12669-cit-0021","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2133.2011.10540.x","article-title":"Repigmentation of leucotrichia in vitiligo with noncultured cellular grafting","volume":"166","author":"Gan","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0022|bjd12669-cit-0022","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/jid.2012.328","article-title":"Activation of the unfolded protein response in vitiligo: the missing link?","volume":"132","author":"Passerson","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12669-BIB0023|bjd12669-cit-0023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.12013","article-title":"The distribution pattern of segmental vitiligo: clues for somatic mosaicism","volume":"168","author":"Geel","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0024|bjd12669-cit-0024","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2133.2012.11111.x","article-title":"Clinical significance of Koebner phenomenon in vitiligo","volume":"167","author":"Geel","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0025|bjd12669-cit-0025","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"issue":"Suppl. 3","key":"10.1111\/bjd.12669-BIB0026|bjd12669-cit-0026","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","article-title":"Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review","volume":"26","author":"Archier","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12669-BIB0027|bjd12669-cit-0027","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archderm.143.5.578","article-title":"Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy","volume":"143","author":"Yones","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12669-BIB0028|bjd12669-cit-0028","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1468-3083.2007.01980.x","article-title":"Narrowband UVB therapy for vitiligo: does the repigmentation last?","volume":"21","author":"Sitek","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12669-BIB0029|bjd12669-cit-0029","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12669-BIB0030|bjd12669-cit-0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2133.2011.10351.x","article-title":"A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0.1% vs. clobetasol propionate 0.05% in childhood vitiligo","volume":"165","author":"Ho","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12669-BIB0031|bjd12669-cit-0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1755-148X.2011.00922.x","article-title":"In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial","volume":"25","author":"Geel","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/bjd.12669-BIB0032|bjd12669-cit-0032","unstructured":"Acne Academy http:\/\/www.acnepsp.org"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12669","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12669\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:07:15Z","timestamp":1676383635000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/170\/3\/565\/6614808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12669","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}